RB
Ravindra Baliram More
About Ravindra Baliram More
Data last updated:
Ravindra Baliram More is a Company Secretary at Medley Pharmaceuticals Limited (since 2014) and Company Secretary at Sinkhai Healthcare Limited (since 2020). The companies operate in Pharma, Consumer Goods and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹1,260 Cr; the largest is Medley Pharmaceuticals Limited at ₹1,115 Cr (FY 2025). Earlier, Ravindra Baliram More was a Company Secretary at Welspun Global Brands Limited (2007–2014) and Company Secretary at Blue-Fin Frozen Foods Private Limited (2015–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medley Pharmaceuticals Limited U24230MH1975PLC018296 | Company Secretary | 01 Dec 2014 | 1975 | ₹1,115 Cr (FY 2025) | Active |
| Sinkhai Healthcare Limited U24230MH2005PLC151938 | Company Secretary | 22 Jul 2020 | 2005 | ₹145 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Welspun Global Brands Limited U71210GJ2004PLC045144 | Company Secretary | 19 Jun 2007 | 2004 | ₹6,550 Cr (FY 2023) | Active |
 Blue-Fin Frozen Foods Private Limited U15139MH2008PTC188502 | Company Secretary | 30 Mar 2015 | 2008 | ₹118 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravindra Baliram More
| Name | DIN | Company | Designation |
|---|---|---|---|
| Devendra Pandurang Bhagat | Medley Pharmaceuticals Limited | Cfo | |
| Mirasif Mirmohsin Ali | 00058250 | Medley Pharmaceuticals Limited | Whole-Time Director |
| Mohamed Aslam Abdul Rahman Sheikh | 03215349 | Medley Pharmaceuticals Limited | Director |
| Saba Mir Asif Ali | 00058184 | Medley Pharmaceuticals Limited | Whole-Time Director |
| Sahir Sami Khatib | 00043681 | Medley Pharmaceuticals Limited | Managing Director |
| Sarosh Sami Khatib | 00058143 | Medley Pharmaceuticals Limited , Sinkhai Healthcare Limited | Whole-Time Director |
| Sucheta Mudgerikar | 10720060 | Medley Pharmaceuticals Limited | Director |
| Suhel Sami Khatib | 00904454 | Medley Pharmaceuticals Limited | Director |
| Shayaan Sarosh Khatib | 07547839 | Sinkhai Healthcare Limited | Director |
| Surendra Kumar Sharma | 01204773 | Sinkhai Healthcare Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravindra Baliram More
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravindra Baliram More
Ravindra Baliram More currently holds 2 directorships: Medley Pharmaceuticals Limited (Company Secretary, since 01 Dec 2014, revenue ₹1,115 Cr (FY 2025)); Sinkhai Healthcare Limited (Company Secretary, since 22 Jul 2020, revenue ₹145 Cr (FY 2025)).
Ravindra Baliram More was first appointed on 19 Jun 2007 as Company Secretary at Welspun Global Brands Limited. The most recent appointment on record is 22 Jul 2020 at Sinkhai Healthcare Limited.
The 2 current companies of Ravindra Baliram More that report revenue have a combined latest revenue of ₹1,260 Cr: Medley Pharmaceuticals Limited ₹1,115 Cr (FY 2025); Sinkhai Healthcare Limited ₹145 Cr (FY 2025).
Ravindra Baliram More held 2 earlier board appointments: Welspun Global Brands Limited (Company Secretary, 19 Jun 2007 to 30 Nov 2014); Blue-Fin Frozen Foods Private Limited (Company Secretary, 30 Mar 2015 to 21 Jul 2020).
The current boards of Ravindra Baliram More's companies include Devendra Pandurang Bhagat (Medley Pharmaceuticals Limited), Mirasif Mirmohsin Ali (Medley Pharmaceuticals Limited), Mohamed Aslam Abdul Rahman Sheikh (Medley Pharmaceuticals Limited), Saba Mir Asif Ali (Medley Pharmaceuticals Limited), Sahir Sami Khatib (Medley Pharmaceuticals Limited), Sarosh Sami Khatib (Medley Pharmaceuticals Limited), among others.